ADAM8 and breast cancer: Since we have shown that ADAM8 is required for β1-integrin activation [24], which is known to participate in adhesion of breast cancer cells to the endothelium [51, 52], we investigated the potential role of the DI/CRD/ELD domains in miR-720 activation.